Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
206 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07815808 | Cardioprotective Effect of Empagliflozin in Breast Cancer Patients | not yet recruiting | Phase 3 | 150 | Tanta UniversityOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT06774885 | Role of Folic Acid in the Management of Adjuvant Endocrine Therapy-Induced Hot Flashes in Breast Cancer Patients | completed | Phase 3 | 120 | Future University in EgyptOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT06418347 |
| Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females |
| completed |
| Phase 3 |
| 150 |
| Ain Shams UniversityOTHER |
| 1 |
| Sep 16, 2026 |
| clinicaltrials |
| NCT07081360 | Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer | recruiting | Phase 3 | 262 | Minia UniversityOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT07585396 | Inositol in Letrozol Resistant PCOS Women | completed | Phase 2 / Phase 3 | 136 | Kafrelsheikh UniversityOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT05972928 | Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients | completed | Phase 2 / Phase 3 | 80 | Beni-Suef UniversityOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT04770896 | A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab(IMbrave251) | active not recruiting | Phase 3 | 557 | Hoffmann-La RocheINDUSTRY | 28 | Aug 25, 2026 | clinicaltrials |
| NCT05965908 | Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome | completed | Phase 3 | 183 | Beni-Suef UniversityOTHER | 1 | Aug 25, 2026 | clinicaltrials |
| NCT06862115 | The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult Patients Undergoing Colorectal Cancer Surgery | completed | Phase 3 | 182 | Kasr El Aini HospitalOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT03847428 | Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment(EMERALD-2) | active not recruiting | Phase 3 | 908 | AstraZenecaINDUSTRY | 24 | Aug 14, 2026 | clinicaltrials |
| NCT07736495 | Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis | recruiting | Phase 2 / Phase 3 | 50 | Ain Shams UniversityOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT05296798 | A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) | active not recruiting | Phase 3 | 922 | Hoffmann-La RocheINDUSTRY | 29 | Jul 16, 2026 | clinicaltrials |
| NCT03456076 | A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer | active not recruiting | Phase 3 | 257 | Hoffmann-La RocheINDUSTRY | 27 | Jul 15, 2026 | clinicaltrials |
| NCT05301842 | Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC(EMERALD-3) | active not recruiting | Phase 3 | 760 | AstraZenecaINDUSTRY | 22 | Jul 13, 2026 | clinicaltrials |
| NCT07658508 | Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia | active not recruiting | Phase 2 / Phase 3 | 30 | Alexandria UniversityOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT04961996 | A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) | active not recruiting | Phase 3 | 4,170 | Hoffmann-La RocheINDUSTRY | 54 | Jun 17, 2026 | clinicaltrials |
| NCT07627906 | Ketofol Versus Ketodex for POD Prophylaxis in Elderly Cancer Surgery | recruiting | Phase 3 | 180 | Cairo UniversityOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT01046825 | Mature B-Cell Lymphoma And Leukemia Study III | active not recruiting | Phase 2 / Phase 3 | 128 | St. Jude Children's Research HospitalOTHER | 3 | Jun 2, 2026 | clinicaltrials |
| NCT06405178 | Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome | completed | Phase 3 | 200 | Beni-Suef UniversityOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT02075840 | A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants(ALEX) | completed | Phase 3 | 303 | Hoffmann-La RocheINDUSTRY | 29 | May 29, 2026 | clinicaltrials |
| NCT02106572 | Therapeutic Instillation of Mistletoe(TIM) | terminated | Phase 3 | 174 | Abnoba GmbhINDUSTRY | 2 | May 22, 2026 | clinicaltrials |
| NCT05566795 | DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) | active not recruiting | Phase 3 | 418 | Day One Biopharmaceuticals, Inc.INDUSTRY | 30 | May 14, 2026 | clinicaltrials |
| NCT02771405 | Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC(FRI-STC) | completed | Phase 3 | 150 | National Hepatology & Tropical Medicine Research InstituteOTHER_GOV | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07504198 | Neuroprotection of Memantine and Rosuvastatin | not yet recruiting | Phase 2 / Phase 3 | 46 | Tanta UniversityOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07476443 | Renoprotective Role of Vitamin C and Coenzyme Q10 in Nephrotoxicity(VitC-CoQ10) | not yet recruiting | Phase 2 / Phase 3 | 75 | Ain Shams UniversityOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT07450508 | Study of Bendamustine, Gemcitabine and Vinorelbine Regimen in Relapsed/Refractory Classical Hodgkin Lymphoma(BEGEV) | completed | Phase 3 | 88 | Cairo UniversityOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT07434206 | Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors | active not recruiting | Phase 2 / Phase 3 | 80 | South Egypt Cancer InstituteOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT03063073 | Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block(pec's) | completed | Phase 3 | 60 | South Egypt Cancer InstituteOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT00066703 | Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer(TEXT) | completed | Phase 3 | 2,672 | ETOP IBCSG Partners FoundationNETWORK | 17 | Feb 6, 2026 | clinicaltrials |
| NCT01856478 | LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy | completed | Phase 3 | 340 | Boehringer IngelheimINDUSTRY | 8 | Jan 12, 2026 | clinicaltrials |
| NCT07279792 | Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection | completed | Phase 2 / Phase 3 | 150 | Ain Shams UniversityOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07287592 | Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer. | not yet recruiting | Phase 3 | 70 | Ain Shams UniversityOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT07155525 | Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas(NBCA-MS) | recruiting | Phase 3 | 194 | Minia UniversityOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07165262 | Effect of Different Anesthetic Drugs on Electrocorticography (ECOG).(ECOG-Anaes) | active not recruiting | Phase 3 | 88 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT05680870 | The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients | completed | Phase 3 | 46 | Aya Mohamed Sadek ElsaidOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT00002462 | RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | active not recruiting | Phase 3 | 615 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Aug 5, 2025 | clinicaltrials |
| NCT06728982 | Impact Of Metformin In Rectal Cancer Patients | completed | Phase 2 / Phase 3 | 85 | Minia UniversityOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06836128 | The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients(PCOS) | recruiting | Phase 3 | 102 | Cairo UniversityOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT05624138 | The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy | recruiting | Phase 3 | 64 | Tanta UniversityOTHER | 1 | May 11, 2025 | clinicaltrials |
| NCT06947330 | Comparison Between Erector Spinae Plane Block Versus Serratus Anterior Plane Block Regarding Analgesia Post Modified Radical Mastectomy(FMASUMD66/2025) | recruiting | Phase 3 | 100 | Kholoud UsamaOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT06853951 | Cardioprotection on Chemotherapy-Induced Cardiotoxicity | recruiting | Phase 3 | 30 | Ain Shams UniversityOTHER | 1 | Mar 3, 2025 | clinicaltrials |
| NCT06815094 | Erector Spinae Plane Block Versus Caudal Epidural Analgesia | completed | Phase 2 / Phase 3 | 32 | National Cancer Institute, EgyptOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT06115408 | Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma | completed | Phase 2 / Phase 3 | 40 | Ain Shams UniversityOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT06576375 | Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome | unknown | Phase 3 | 70 | Future University in EgyptOTHER | 1 | Oct 22, 2024 | clinicaltrials |
| NCT05243251 | Olanzapine Anorexia Cachexia | completed | Phase 3 | 164 | Cairo UniversityOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT05465369 | Clinical Assessment of Injectable Flowable Composite with Giomer Technology Vs High Viscosity Glass Ionomer Restorations in ART for Cancer Patients | completed | Phase 3 | 190 | Cairo UniversityOTHER | 1 | Sep 25, 2024 | clinicaltrials |
| NCT04776083 | Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients | completed | Phase 3 | 75 | Menoufia UniversityOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05822934 | Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer | unknown | Phase 3 | 20 | Assiut UniversityOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06005558 | Low Dose Versus High Dose Methylene Blue in Septic Patients | completed | Phase 2 / Phase 3 | 90 | National Cancer Institute, EgyptOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT06486870 | Comparison Between Two Ovulation Induction Therapies and LOD on Clinical Outcomes in CC-Resistant PCOS Women | completed | Phase 3 | 183 | Cairo UniversityOTHER | 1 | Jul 5, 2024 | clinicaltrials |
Data updated 4 days agoSource updated unknownsource: clinicaltrials